REGENERON PHARMACEUTICALS (REGN) Stock News
NASDAQ:REGN - Nasdaq - US75886F1075 - Common Stock - Currency: USD
REGN Latest News, Press Relases and Analysis
Let's take a look at the S&P500 stocks that are experiencing unusual volume in today's session.
Let's take a closer look at the S&P500 stocks with an unusual volume in today's session on Thursday. Stay informed about the market activity below.
Discover which S&P500 stocks are making waves on Thursday.
Join us in exploring the top gainers and losers within the S&P500 index in the middle of the day on Thursday as we examine the latest happenings in today's session.
Thursday's session: gap up and gap down stock in the S&P500 index
Wondering which stocks are making significant price gaps? Explore the S&P500 index on Thursday to find the gap up and gap down stocks in today's session.
Regeneron Pharmaceuticals, Inc. (REGN): Among the Cheap ESG Stocks to Buy According to Hedge Funds
We recently compiled a list of the 11 Cheap ESG Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) stands against the other cheap ESG stocks. These days, it seems like everyone wants to wear the “saving the world” cape. Whether this […]
These S&P500 stocks that are showing activity before the opening bell on Thursday.
Stay updated with the S&P500 stocks that are on the move in today's pre-market session.
Regeneron Pharmaceuticals (REGN): Among Billionaire Mario Gabelli’s Large-Cap Stock Picks with Huge Upside Potential
We recently published a list of Billionaire Mario Gabelli’s 10 Large-Cap Stock Picks with Huge Upside Potential. In this article, we are going to take a look at where Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) stands against Billionaire Mario Gabelli’s other large-cap stock picks with huge upside potential. Mario Gabelli needs no introduction, having risen to become […]
What's going on in today's session: S&P500 movers
Uncover the latest developments among S&P500 stocks in today's session. Stay tuned to the S&P500 index's top gainers and losers on Tuesday.
Uncover the latest developments among S&P500 stocks in today's session.
Let's have a look at the top S&P500 gainers and losers in the middle of the day of today's session.
If You Invested $100 In This Stock 15 Years Ago, You Would Have This Much Today
Regeneron price target lowered to $940 from $975 at Truist
Truist lowered the firm’s price target on Regeneron (REGN) to $940 from $975 but keeps a Buy rating on the shares. The firm is reducing its expected Eylea sales given the company’s near-term outlook, though while near-term investor focus remains on the Eylea tail, Regeneron continues to deliver growth on top/bottom line in the near to longer-term with Dupi and Libtayo, the analyst tells investors in a research note. Published first on TheFly – the ultimate source for real-time, market-moving bre
Regeneron to Highlight Advances at ASCO with Phase 3 Adjuvant Libtayo® (cemiplimab) CSCC Updates and Promising Early Blood Cancer Data with Linvoseltamab Combination
18 presentations across five cancer types include new insights on the potential of checkpoint inhibitors and bispecific antibodies
Regeneron to Highlight Advances at ASCO with Phase 3 Adjuvant Libtayo® (cemiplimab) CSCC Updates and Promising Early Blood Cancer Data with Linvoseltamab Combination
18 presentations across five cancer types include new insights on the potential of checkpoint inhibitors and bispecific antibodies...
Dupixent® (dupilumab) Data Presented at ATS Reinforce Impact of Targeting Key Type 2 Inflammation Drivers to Improve Outcomes for Chronic Respiratory Diseases
Dupixent® (dupilumab) Data Presented at ATS Reinforce Impact of Targeting Key Type 2 Inflammation Drivers to Improve Outcomes for Chronic Respiratory Diseases
24 abstracts, including 1 oral presentation and 4 late-breaking posters on Dupixent, to showcase new clinical and real-world analyses in chronic...
Despite its impressive fundamentals,REGENERON PHARMACEUTICALS (NASDAQ:REGN) remains undervalued.
REGENERON PHARMACEUTICALS has caught the attention as a great value stock. NASDAQ:REGN excels in profitability, solvency, and liquidity, all while being very reasonably priced.
Top S&P500 movers in Wednesday's session
Stay updated with the movements of the S&P500 index one hour before the close of the markets on Wednesday. Discover which stocks are leading as top gainers and losers in today's session.
Jim Cramer on Micron (MU): “No Catalyst, But You’re Buying Near the Low End”
We recently published a list of Jim Cramer Recently Discussed These 9 Stocks. In this article, we are going to take a look at where Micron Technology, Inc. (NASDAQ:MU) stands against other stocks that Jim Cramer discussed recently. Jim Cramer, the host of Mad Money, discussed the current economic outlook on Monday as he outlined […]
These S&P500 stocks are moving in today's session
Stay updated with the movement of S&P500 stocks in today's session. Discover which S&P500 stocks are making waves on Wednesday.
Company News for Apr 30, 2025
Companies In The News Are: NUE, REGN, PYPL, PFE.
These 3 Funds Offer Sky-High Yields of 15% or More and Trade at a Discount
Salesforce, Inc. (CRM): Among Billionaire Stephen Mandel’s Stocks with Huge Upside Potential
We recently published a list of Billionaire Stephen Mandel’s 10 Stocks with Huge Upside Potential. In this article, we are going to take a look at where Salesforce, Inc. (NYSE:CRM) stands against other billionaire Stephen Mandel’s stocks with huge upside potential. With economic policy and trade tensions fueling volatility, investors are moving through one of […]
ProQR Therapeutics assumed with an Overweight at Cantor Fitzgerald
Cantor Fitzgerald analyst Steve Seedhouse assumed coverage of ProQR Therapeutics (PRQR) with an Overweight rating and $8 price target ProQR is a leader in RNA editing and the initial biomarker data for its first program targeting bile acid transporter in Q4 will be an “important catalyst,” the analyst tells investors in a research note. Cantor views the company as a “pure play” on RNA editing. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. T
Types of business lines of credit
Business lines of credit let you use available credit recurringly, and they come in two forms.
Discover which S&P500 stocks are making waves on Tuesday.
Let's delve into the developments on the US markets one hour before the close of the markets on Tuesday. Below, you'll find the top gainers and losers within the S&P500 index during today's session.
Should you cancel an unused credit card?
Sometimes, you should keep a credit card, even if you don’t use it.
What happens to your retail credit card when a store closes?
Here’s how your retail credit card may be impacted by store closures.
Buy now, pay later can now help or hurt your credit score — here’s why
If you’re a BNPL user, here’s what to know about Affirm’s new reporting to Experian.
Regeneron Pharma Margins Tighten As Competition Grows, Stock Slides
On Tuesday, Regeneron Pharmaceuticals Inc (NASDAQ:REGN) reported first-quarter adjusted earnings per share of $8.22, down 14% year-over-year, missing the consensus of $8.82. The company reported sales of $3.03 billion, down 4%, missing the consensus of $3.29 billion. In the first quarter, U.S. net sales for Eylea HD and Eylea decreased 26% year-over-year to $1.04 billion, including $307 million from Eylea HD. Also Read: FDA Sets The Countdown: Regeneron’s Eylea HD Could Be Headed For Major Expan
Why Regeneron (REGN) Stock Is Falling Today
Shares of biotech company Regeneron (NASDAQ:REGN) fell 9.6% in the morning session after the company reported weak first-quarter 2025 results. Its revenue missed significantly, and its EPS fell short of Wall Street's estimates. Revenue declined 4% from the prior year, as Regeneron struggled to offset the double-digit decline in net product sales, including a 29% plunge in legacy EYLEA, despite a 54% jump in EYLEA HD. Overall, this quarter could have been better.
Exploring the top movers within the S&P500 index during today's session.
Stay updated with the movements of the S&P500 index in the middle of the day on Tuesday. Discover which stocks are leading as top gainers and losers in today's session.
Which S&P500 stocks are gapping on Tuesday?
Wondering what's happening in today's session regarding gap up and gap down stocks? Explore the S&P500 index on Tuesday to uncover the stocks that are gapping in the S&P500 index.
Tuesday's pre-market session: top gainers and losers in the S&P500 index
The US market session of Tuesday has yet to be opened, let's have a look at the top S&P500 gainers and losers in the pre-market session today.
Why REGENERON PHARMACEUTICALS (NASDAQ:REGN) Deserves Consideration as a Quality Investment.
A fundamental analysis of (NASDAQ:REGN): Should Quality Investors Include NASDAQ:REGN in Their Portfolio?
Discover which S&P500 stocks are making waves on Monday.
Curious about the S&P500 stocks that are in motion on Monday? Join us as we explore the top movers within the S&P500 index during today's session.